Belantamab Mafodotin,Pomalidomide,Dexamethasone
gsk
['dreamm,9', 'belantamab', 'belantamab,mafodotin', 'dreamm', 'mmsm', 'multiplemyeloma']
today at 3 p.m. ct at #asco23. katja weisel ( ) will discuss the interim analysis of the dreamm 9 phase 1 trial of belantamab mafodotin in combo w/ standard of care in newly diagnosed #multiplemyeloma. is first author of the study #mmsm 
The official account of @MSKCancerCenter’s Department of Medicine. Chair/Dept. Head: @debschrag